Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
the firm's price target on the shares and reports highlighted significant challenges in the company's product portfolio. The analyst trimmed the price target to $30 from $31 while keeping a Neutral rating. Adding to the pressure, the company faced headwinds for its iron sucrose and glucagon products, with sales expected to be much lower than previously thought due to increased competition. For instance, iron sucrose sales were forecasted at around $5 million per quarter, and glucagon sales were anticipated to trend down. Consequently, the company's growth outlook was moderated from double-digit expectations to a range of high-single to low-double digits. This news followed a nearly 4% drop in the stock during the previous trading session, suggesting continued investor concern. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Amphastar Pharmaceuticals? Access our full analysis report here, i
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- 2 Reasons to Avoid AMPH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound [Yahoo! Finance]Yahoo! Finance
- Amphastar Director Sells 16,679 Shares for $441,800 [Yahoo! Finance]Yahoo! Finance
- Will FDA Approval of an In-House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 11/6/25 - Beat
AMPH
Sec Filings
- 1/12/26 - Form 8-K
- 12/18/25 - Form 4
- 12/15/25 - Form 4
- AMPH's page on the SEC website